Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)

NCT00174408 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1990
Completion date
February 28, 2005
Enrollment
110
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth disorders